Feasibility of Percutaneous Posterolateral Spinal Fusion with Recombinant Bone Morphogenetic Protein-2 (rh-BMP2): A Comparison With Standard Methods Using an Animal Model Study

Chan CY 1 , Kwan MK , Saw LB , Hussin P

Affiliations 

  • 1 *Department of Orthopaedic Surgery, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia†Department of Orthopaedic, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia
Clin Spine Surg, 2016 May 26.
PMID: 24141340

Abstract

The clinical application of recombinant bone morphogenetic protein in spinal surgery has been shown to be safe and effective. However, its use in minimally invasive spine surgery has been limited to anterior interbody fusion procedures. To date, no study has evaluated the feasibility of percutaneous posterolateral fusion in the spine utilizing rhBMP-2.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications